Machine Learning Opticyte Earns FDA Breakthrough Device Designation for the First Cell O2 Patient Monitor for Organ… AIT News Desk Jan 9, 2023 Opticyte leverages proprietary machine learning to noninvasively assess organ dysfunction due to low cellular oxygenation in patients of all skin…
Life Sciences Opticyte Secures $4.6 Million in Funding to Develop First Cell O2 Monitor for Reducing Organ Failure AIT News Desk Jan 12, 2021 Opticyte obtains funding from a $2.9MM SBIR Phase IIB grant and completes a $1.7MM seed round to launch first observational trial of Opticyte Cell…